| 000 | 01391nam a22002417a 4500 | ||
|---|---|---|---|
| 999 |
_c8201 _d8201 |
||
| 003 | MED20080001 | ||
| 005 | 20240720152619.0 | ||
| 008 | 160505b2008 xxu||||| |||| 00| 0 eng d | ||
| 040 | _cFEU-NRMF MEDICAL LIBRARY | ||
| 041 | _aEnglish | ||
| 050 | _aMED20080001 | ||
| 100 |
_aManjares, Paulyn T., MD. _eauthor |
||
| 245 |
_aAgranulocytosis in anti-thyroid medications / _cPaulyn T. Manjares. |
||
| 260 |
_aFairview, Quezon City _bDepartment of Medicine, FEU-NRMF, _c2008 |
||
| 300 | _c(in folder) | ||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 520 | _aABSTRACT: Agranulocytosis is a rare complication of antithyroid drugs. Agranulocytosis is defined as absolute neutropil count, ANC <500x10/l and may develop in 0.2-0.5% of patients taking antithyroid drugs.A case of L.S., 35 y/o female admitted due to fever diagnosed to have hyperthyroidism last 2000 maintained on Tapazole irregularly taken, Patient was taking Strumazole for 1 month. PE: (+) exedates and hypermic pharyngeal wall, thyroid gland palpable, bilateral; adynamic precordium, tachcardic and regular rhythm. Neurologic Exam : unremarkable. In the ward, patient was given Ceftazidime, G-CSF, Paracetamol, Clindamycin, Propranolol, and Multivitamins. Prior to discharge, patient had RAI at 6 MCI | ||
| 521 | _aRESDM | ||
| 887 | _aR00291 | ||
| 942 |
_2lcc _cRE |
||